secwatch.observer — SEC 8-K summary
======================================

Issuer:     LENZ Therapeutics, Inc. (LENZ)
CIK:        0001815776
Form:       8-K
Filed at:   2026-06-12T20:08:05+00:00
Accession:  0001815776-26-000041
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

LENZ Therapeutics shareholders elect three Class II directors and ratify auditor at 2026 annual meeting.
--------------------------------------------------------------------------------

- Votes for Evert Schimmelpennink: 20,216,637; withheld: 230,219; broker non-votes: 3,995,212.
- Votes for Jeff George: 13,462,359; withheld: 6,984,497; broker non-votes: 3,995,212.
- Votes for Shelley Thunen: 20,215,686; withheld: 231,170; broker non-votes: 3,995,212.
- Ratification of Ernst & Young as auditor passed: 24,310,915 for, 55,181 against, 75,972 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815776/000181577626000041/0001815776-26-000041-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815776/000181577626000041/lenz-20260612.htm
  HTML page:      https://secwatch.observer/filing/0001815776-26-000041

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer